IL17A and systemic sclerosis: Nevertheless, the regulatory effect of Fli-1 on expression of interleukins including IL-1β, IL-4, IL-6, IL-10, IL-12a, IL-17A, and IL-33 is the opposite in skin samples from a bleomycin-induced SSc murine model [23,24].